CA
NZ
UK
AU
IND
US
Last-twelve-month cash from operations was USD 3.1 billion and freeCash FlowUSD 2.0 billion, a 53% conversion of adjusted EBITDA, or 61% excluding USD 306 million of deposits to Canada tied to a United States and CanadaTransfer Pricingmatter. Management notes those deposits will be applied …
GAAP net income was USD 85 million versus USD 18 million, while adjusted net income was USD 90 million versus USD 56 million. The year-ago quarter is distorted by the commercial partnership with a medical lab automation channel partner, so excluding it adjusted EPS …
Net cash fromOperating Activitieswas USD 781.4 million, adjusted EBITDA (non-GAAP) was USD 871.3 million and adjusted freeCash Flowwas USD 431.5 million, or USD 442 million excluding reimbursableCapitalspending. The release text pairs USD 871.3 million with operating cash flow, but the tables show it as …
Key HighlightsXeris Biopharma Holdings, Inc. (NASDAQ:XERS) rose 29.68% after third quarterRevenueclimbed 44% to USD 107.2 million and the 2030 revenue outlook was lifted above USD 1 billion.Vericel Corporation (NASDAQ:VCEL) gained 20.27% after revenue grew 26% to USD 85.4 million and full-year guidance was raised …
The financial technology company offers low-cost banking and payments products, with deposits insured through partner banks. MyPay origination volume hit a record USD 5.3 billion with loss rates around 1%, annualized revenue above USD 500 million and record transaction profit of USD 80 million. …
Key HighlightsVeracyte, Inc. (NASDAQ:VCYT) fell 54.9% and MNTN fell 54% after results released on November 4, 2026, both tied to lower guidance rather than a collapse in the reported quarter.BuzzFeed, Inc. (NASDAQ:BZFD) fell 38% after third quarterRevenuedropped 44% to USD 26.0 million and management …
Key HighlightsNet income was USD 3.9 million for the third quarter of 2026, versus a net loss of USD 8.8 million a year earlier, after a USD 6.3 million loss from operations.Fair value gains of USD 7.5 million onWarrantliabilities and USD 3.4 million on …
Key HighlightsLakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) was quoted 290.33% higher after retiring all Series C preferred stock for USD 1,270,970, a nano-cap move on about 45 times normal volume.Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) rose 29.68% on 44%Revenuegrowth to USD 107.2 million, raised 2026 guidance and …
Adjusted SG&A (non-GAAP) rose 60.1% to USD 113.8 million, or 15.0% of revenue against 14.3%. The company, which uses its Clover Assistant software to support physician care ofMedicareAdvantage members, said its flagship PPO, about 98% of current membership, received a 5 Star rating for …
Key HighlightsVeracyte, Inc. (NASDAQ:VCYT) fell 54.9% to USD 23.69 after lowering 2026 testingRevenueguidance, even though third quarter revenue rose 15% to USD 151.8 million.Akebia Therapeutics (NASDAQ:AKBA) fell 33.91% to USD 0.4591 after third quarter revenue dropped to USD 36.9 million from USD 58.8 million …
Please wait processing your request...